XLIXPPAR-α

Panpan Zhao1, Wei Zhang2, Xinyu Zhou3

  • 1Department of Neurosurgery, Institute of Neuroscience, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang Clinical College of Nanjing Medical University, The First People's Hospital of Lianyungang, Lianyungang 222000, China.

Experimental neurology
|November 3, 2024
PubMed
概括

新型治疗药物Gyp-XLIX在治疗败血症相关脑病变 (SAE) 中表现有前途. 在临床前模型中,这种化合物通过减少炎症和氧化应激来改善生存率并保护大脑组织.